Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Oracle
ORCL
|
+$967M |
| 2 |
DoorDash
DASH
|
+$472M |
| 3 |
Amgen
AMGN
|
+$391M |
| 4 |
Amazon
AMZN
|
+$304M |
| 5 |
Applied Materials
AMAT
|
+$260M |
Top Sells
| 1 |
Abbott
ABT
|
+$587M |
| 2 |
Workday
WDAY
|
+$556M |
| 3 |
United Parcel Service
UPS
|
+$458M |
| 4 |
Apple
AAPL
|
+$413M |
| 5 |
Atlassian
TEAM
|
+$383M |
Sector Composition
| 1 | Technology | 32.99% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Olema Pharmaceuticals
OLMA
$511M
| $13.8M | 0.01% |
1,221,662
+521,562
| +74% | +$5.9M |
|
627
Digital Realty Trust
DLR
$55.9B
| $13.8M | 0.01% |
95,626
+2,190
| +2% | +$315K |
|
628
Vanguard Total International Bond ETF
BNDX
$68.4B
| $13.8M | 0.01% |
279,666
-1,539
| -0.5% | -$75.7K |
|
629
Colgate-Palmolive
CL
$68.1B
| $13.7M | 0.01% |
151,939
-60,077
| -28% | -$5.41M |
|
|
KAMN
630
DELISTED
Kaman Corp
KAMN
| $13.6M | 0.01% |
297,210
+286,118
| +2,579% | +$13.1M |
|
631
Kornit Digital
KRNT
$680M
| $13.6M | 0.01% |
750,944
-8,925
| -1% | -$162K |
|
632
LoveSac
LOVE
$281M
| $13.6M | 0.01% |
601,870
-6,689
| -1% | -$151K |
|
|
SLN
633
Silence Therapeutics
SLN
$254M
| $13.6M | 0.01% |
+625,864
| New | +$13.6M |
|
634
Asure Software
ASUR
$222M
| $13.5M | 0.01% |
1,737,398
+1,043,385
| +150% | +$8.12M |
|
635
CryoPort
CYRX
$503M
| $13.5M | 0.01% |
761,772
-8,326
| -1% | -$147K |
|
636
Corbus Pharmaceuticals
CRBP
$121M
| $13.4M | 0.01% |
+339,074
| New | +$13.4M |
|
637
Emcor
EME
$27.9B
| $13.2M | 0.01% |
37,611
+15,066
| +67% | +$5.28M |
|
638
Terns Pharmaceuticals
TERN
$661M
| $13.1M | 0.01% |
2,003,263
+578,500
| +41% | +$3.79M |
|
639
Compass Therapeutics
CMPX
$597M
| $12.8M | 0.01% |
6,492,900
-54,331
| -0.8% | -$107K |
|
|
B
640
Barrick Mining Corporation
B
$49.7B
| $12.8M | 0.01% |
768,906
-10,000
| -1% | -$166K |
|
641
Savara
SVRA
$660M
| $12.8M | 0.01% |
2,563,620
+746,407
| +41% | +$3.71M |
|
642
Ecolab
ECL
$78.1B
| $12.6M | 0.01% |
54,756
-15,221
| -22% | -$3.51M |
|
643
Charles River Laboratories
CRL
$7.97B
| $12.6M | 0.01% |
46,571
-32,964
| -41% | -$8.93M |
|
644
Enliven Therapeutics
ELVN
$1.19B
| $12.6M | 0.01% |
713,911
+305,397
| +75% | +$5.39M |
|
645
AerCap
AER
$21.9B
| $12.4M | 0.01% |
142,539
+33,852
| +31% | +$2.94M |
|
646
US Bancorp
USB
$76.8B
| $12.4M | 0.01% |
276,599
+16,686
| +6% | +$746K |
|
647
CorVel
CRVL
$4.64B
| $12.4M | 0.01% |
140,925
+128,088
| +998% | +$11.2M |
|
648
Toronto Dominion Bank
TD
$128B
| $12.3M | 0.01% |
203,781
-142,105
| -41% | -$8.58M |
|
|
AXNX
649
DELISTED
Axonics, Inc. Common Stock
AXNX
| $12.3M | 0.01% |
178,322
+154,149
| +638% | +$10.6M |
|
650
Newmont
NEM
$83.4B
| $12.3M | 0.01% |
341,907
+54,761
| +19% | +$1.96M |
|